Negative EMA opinion for the ipilimumab/nivolumab combination
Yesterday it was announced that the combination of ipilimumab and [...]
Yesterday it was announced that the combination of ipilimumab and [...]
A recent meta-analysis evaluating the efficacy of first- and second-line [...]
The following interview with Dr Eric Jonasch, medical oncologist from [...]
Patient-reported outcomes data from the Phase 3 CheckMate-214 trial of [...]
The US Food and Drug Administration (FDA) has granted approval [...]
Overall survival data for the ipilimumab-nivolumab combination versus sunitinib from [...]
Further to the results from recent studies, particularly CheckMate-214, the [...]
Bristol-Myers Squibb and Nektar Therapeutics are working together to develop a cancer therapy [...]
The following is a Practice Update interview with Dr Hans Hammers, Associate [...]
In his keynote lecture at the American Society for Clinical [...]